sdz nvi-085 has been researched along with prazosin in 6 studies
Studies (sdz nvi-085) | Trials (sdz nvi-085) | Recent Studies (post-2010) (sdz nvi-085) | Studies (prazosin) | Trials (prazosin) | Recent Studies (post-2010) (prazosin) |
---|---|---|---|---|---|
10 | 1 | 0 | 7,914 | 713 | 682 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dement, WC; Guilleminault, C; Mignot, E; Nishino, S; Renaud, A | 1 |
Büscher, R; Insel, PA; Michel, MC | 1 |
Oriowo, MA | 1 |
Kalkman, HO; Neumann, V | 1 |
Clarke, DE; Ford, AP; Lachnit, WG | 1 |
Hasegawa, Y; Ono, H; Wada, T | 1 |
6 other study(ies) available for sdz nvi-085 and prazosin
Article | Year |
---|---|
Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Body Temperature; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cataplexy; Disease Models, Animal; Dogs; Eating; Heart Rate; Narcolepsy; Oxazines; Play and Playthings; Prazosin; Radioligand Assay; Yohimbine | 1991 |
Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?
Topics: Adrenergic alpha-Agonists; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cattle; Cell Line; Cerebral Cortex; Clonidine; In Vitro Techniques; Inositol Phosphates; Kidney; Norepinephrine; Oxazines; Prazosin; Rats; Receptors, Adrenergic, alpha; Spleen; Transfection | 1994 |
Alpha 1-adrenoceptor subtype(s) mediating noradrenaline-induced contractions of the guinea-pig aorta.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Clonidine; Dioxanes; Female; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Oxazines; Prazosin; Receptors, Adrenergic, alpha-1 | 1994 |
Evidence for a 5-HT1D receptor-mediated hypothermic effect of the alpha 1-adrenoceptor agonist, SDZ NVI-085, in guinea-pigs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Body Temperature; Bridged-Ring Compounds; Clonidine; Guinea Pigs; In Vitro Techniques; Male; Oxadiazoles; Oxazines; Piperazines; Prazosin; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Bridged-Ring Compounds; Idazoxan; Ketanserin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Oxazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Regional Blood Flow; Serotonin Antagonists; Tail | 1996 |
Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Bridged-Ring Compounds; Clonidine; Dioxanes; Dose-Response Relationship, Drug; Electric Stimulation; Epinephrine; Male; Methoxamine; Motor Neurons; Norepinephrine; Oxazines; Phenylephrine; Piperazines; Prazosin; Rats; Rats, Wistar; Spinal Cord | 1997 |